Business Courses

Enal Razvi, Managing Director, Select Biosciences Inc Enal Razvi, PhD is biotechnology analyst and Managing Director US at Select Biosciences. In this capacity he continuously tracks a number of fields in the scope of his industry coverage, authors market analysis reports in these areas, and works with companies worldwide in the areas of technology analysis, market research, strategy development, and operational roles. Dr. Razvi holds a doctoral degree in the biomedical sciences and was post-doctoral fellow under Ralph Steinman [Nobel Laureate in 2011] at The Rockefeller University, New York. For the last decade, Dr. Razvi has been focused on tracking the life sciences fields and has worked with numerous companies around the world. Dr. Razvi can be reached at: enal@selectbio.us
Akiko Futamura, President and Chief Executive Officer, InfiniteBio Dr. Akiko Futamura is the President and Chief Executive Officer of InfiniteBio, San Jose, California formerly known as SC BioSciences USA. She has extensive background in the business and science of biotechnology. Before Dr. Futamura spun-out InfiniteBio from Sumitomo Corporation in April, 2006, she was the founding member and the Executive Vice President of SC BioSciences USA from 2001-2006. SC BioSciences was the subsidiary of the Sumitomo Corporation which is very active in identifying and introducing cutting-edge biotechnology innovation to the Japanese market. Dr. Futamura was responsible for identifying key technologies, conducting due diligence and involved in business development at therapeutics and platform (tool) companies playing a key role in concluding a number of important alliances and investments. Prior to founding SC BioSciences USA, Dr. Futamura worked as a biotech consultant for Sumitomo Corporation from 1999-2001. She was also the Vice President of Summit Biotech from 2001-2004 where she was one of the primary decision makers conducting investment activities using Sumitomo Corporation’s Summit Biotechnology Fund. Dr. Futamura obtained her B.S. in Biotechnology from University of Tokyo and a Ph.D in Biochemistry from the University of Illinois Medical School, Chicago.